H-Asp-Cys(1)-Leu-Gly-Phe-Met-Arg-Lys-Cys(2)-Ile-Pro-Asp-Asn-Asp-Lys-Cys(3)-Cys(1)-Arg-Pro-Asn-Leu-Val-Cys(2)-Ser-Arg-Thr-1Nal-Lys-Trp-Cys(3)-Lys-Tyr-Val-Phe-NH2

InChIKey	`XJXFPLHCRFQLST-AMOKUYCZSA-N`
Compound Name	H-Asp-Cys(1)-Leu-Gly-Phe-Met-Arg-Lys-Cys(2)-Ile-Pro-Asp-Asn-Asp-Lys-Cys(3)-Cys(1)-Arg-Pro-Asn-Leu-Val-Cys(2)-Ser-Arg-Thr-1Nal-Lys-Trp-Cys(3)-Lys-Tyr-Val-Phe-NH2
Canonical SMILES	CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2cccc4ccccc24)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	6.29
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q15858	SCN9A	Homo sapiens	Human	PF00520 PF24609 PF06512 PF11933	6.6	IC50	ChEMBL;BindingDB
P35499	SCN4A	Homo sapiens	Human	PF00520 PF24609 PF06512	6.2	IC50	ChEMBL;BindingDB
Q14524	SCN5A	Homo sapiens	Human	PF00520 PF24609 PF06512 PF11933	6.0	IC50	ChEMBL;BindingDB